Chemical Structure : BBDDL2059
Catalog No.: PC-20858Not For Human Use, Lab Use Only.
BBDDL2059 (BBDDL 2059) is a potent, selective and covalent inhibitor of EZH2 with IC50 of 1.5 nM (EZH2-Y641F), targeting the Cys663 of EZH2.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BBDDL2059 (BBDDL 2059) is a potent, selective and covalent inhibitor of EZH2 with IC50 of 1.5 nM (EZH2-Y641F), targeting the Cys663 of EZH2.
BBDDL2059 demonstrates excellent cellular potency with IC50 values of 0.064 and 0.022 μM in inhibition of KARPAS-422 and Pfeiffer cell growth, respectively.
BBDDL2059 shows no significant inhibitionagainst a panel of 10 methyltransferases at 10 uM, including DNA methyltransferase DNMT1, arginine methyltransferases (PRMT1, PRMT4, and PRMT5), and protein lysine methyltransferases (G9a, GLP, MLL1, and MLL4).
BBDDL2059 (0.05-1 uM) effectively reduced the H2K27me3 mark in a concentration- and time- dependent manner but had no effect on the total H3 and EZH2 in KARPAS-422 cells.
M.Wt | 512.67 | |
Formula | C27H36N4O4S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Yi Zhang, et al. Journal of Medicinal Chemistry, 2023
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright